Bioxytran (BIXT) Stock Statistics & Valuation Metrics

Bioxytran has a market cap or net worth of $8.58M. The enterprise value is $9.43M.

Bioxytran has 88,992,240 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioxytran’s return on equity (ROE) is 1.32 and return on invested capital (ROIC) is 316.77%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Bioxytran had revenue of 0.00 and earned -2.37M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -147.49K and capital expenditures -22.20K, giving a free cash flow of -169.69K billion.

Bioxytran pays an annual dividend of ―, resulting in a dividend yield of ―

Bioxytran upcoming earnings date is ―, ―.

Bioxytran as a current ratio of <0.01, with Debt / Equity ratio of 0.00%

In the past 12 months, Bioxytran has paid -13.32K in taxes.

Bioxytran EV to EBITDA ratio is -6.09, with an EV/FCF ratio of -161.43.

Bioxytran has $4.35K in cash and marketable securities with $1.26M in debt, giving a net cash position of $1.26M billion.

Gross margin is 93.20%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Bioxytran is ―, which is 11.43% higher than the current price. The consensus rating is ―